Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04155 (
pS2
)
1,234
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Steroid receptor RNA activator (SRA), the only known RNA coactivator, augments transactivation by nuclear receptors (NRs). We identified
SLIRP
(SRA stem-loop interacting RNA binding protein) binding to a functional substructure of SRA, STR7.
SLIRP
is expressed in normal and tumor tissues, contains an RNA recognition motif (RRM), represses NR transactivation in a SRA- and RRM-dependent manner, augments the effect of Tamoxifen, and modulates association of SRC-1 with SRA. SHARP, a RRM-containing corepressor, also binds STR7, augmenting repression with
SLIRP
.
SLIRP
colocalizes with SKIP (Chr14q24.3), another NR coregulator, and reduces SKIP-potentiated NR signaling.
SLIRP
is recruited to endogenous promoters (
pS2
and metallothionein), the latter in a SRA-dependent manner, while NCoR promoter recruitment is dependent on
SLIRP
. The majority of the endogenous
SLIRP
resides in the mitochondria. Our data demonstrate that
SLIRP
modulates NR transactivation, suggest it may regulate mitochondrial function, and provide mechanistic insight into interactions between SRA,
SLIRP
, SRC-1, and NCoR.
...
PMID:SLIRP, a small SRA binding protein, is a nuclear receptor corepressor. 1676 38